Bruker (NASDAQ: BRKR) revenue
Bruker reported revenue of $3,437m for fiscal 2025, 2.1% more than in fiscal 2024 ($3,366m). Since fiscal 2016 its revenue has grown by 113.3%, an average growth of 8.8% a year.
Bruker has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −4.1%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $3,437m | +2.1% | $68.2m | 2.0% |
| 2024 | $3,366m | +13.6% | $253.1m | 7.5% |
| 2023 | $2,965m | +17.1% | $436.9m | 14.7% |
| 2022 | $2,531m | +4.7% | $432.7m | 17.1% |
| 2021 | $2,418m | +21.7% | $413.3m | 17.1% |
| 2020 | $1,988m | −4.1% | $248.3m | 12.5% |
| 2019 | $2,073m | +9.3% | $300.9m | 14.5% |
| 2018 | $1,896m | +7.3% | $262.4m | 13.8% |
| 2017 | $1,766m | +9.6% | $219.5m | 12.4% |
| 2016 | $1,611m | — | $181.8m | 11.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Bruker revenue compared with its sector
By revenue for its latest fiscal year, Bruker ranks 78th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Bruker, 2.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 76th | Alnylam Pharmaceuticals | $3,714m | 65.2% |
| 77th | Dentsply Sirona | $3,680m | −3.0% |
| 78th | Bruker | $3,437m | 2.1% |
| 79th | Acadia Healthcare | $3,313m | 5.0% |
| 80th | Surgery Partners | $3,309m | 6.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Bruker
- How much revenue did Bruker make in fiscal 2025?
- Bruker reported revenue of $3,437m for fiscal 2025, compared with $3,366m in fiscal 2024.
- How much has the revenue of Bruker grown?
- Between fiscal 2016 and fiscal 2025 it went from $1,611m to $3,437m: 113.3% more, an average growth of 8.8% a year.
- What was the best year for revenue at Bruker?
- Of its last 10 fiscal years, fiscal 2025, with $3,437m.
- Where does Bruker rank in its sector by revenue?
- It ranks 78th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Bruker come from?
- From the annual report (Form 10-K) that Bruker files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Bruker files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Bruker: the Bruker page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.